| |
| |
|
| Insider
Information: |
Reilly Thomas Charles |
| Relationship: |
|
| City: |
Stamford |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
106,742 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$89,019 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
106,742 |
|
|
| Total
Value |
$89,019 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cara Therapeutics, Inc. |
CARA |
Chief Financial Officer |
2022-03-03 |
37,811 |
2021-08-24 |
0 |
Premium* |
|
|
Amarin Corp Plc |
AMRN |
|
2024-01-31 |
68,931 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMRN |
Amarin Corp Plc |
EVP and CFO |
• – – |
2024-01-31 |
4 |
D |
$1.24 |
$30,444 |
D/D |
(24,552) |
68,931 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
EVP and CFO |
• – – |
2024-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
44,933 |
93,483 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
EVP and CFO |
• – – |
2024-01-10 |
4 |
D |
$0.97 |
$27,475 |
D/D |
(28,325) |
48,550 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
EVP and CFO |
• – – |
2024-01-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
51,500 |
76,875 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
SVP and CFO |
• – – |
2023-07-01 |
4 |
D |
$1.19 |
$9,769 |
D/D |
(8,209) |
25,375 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
SVP and CFO |
• – – |
2023-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,667 |
33,584 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
SVP and CFO |
• – – |
2023-06-20 |
4 |
D |
$1.19 |
$19,536 |
D/D |
(16,417) |
16,917 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
SVP and CFO |
• – – |
2023-06-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,334 |
33,334 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-03-03 |
4 |
AS |
$11.38 |
$23,261 |
D/D |
(2,044) |
37,811 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-02-28 |
4 |
A |
$10.29 |
$54,877 |
D/D |
5,333 |
39,855 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
34,522 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
11,170 |
14,522 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-08-30 |
4 |
AS |
$14.20 |
$28,144 |
D/D |
(1,982) |
3,352 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
5,334 |
5,334 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
